Atea Pharmaceuticals, Inc.
Industry: Life Sciences ・ $AVIR on Nasdaq
Insider Sale
+$1,024,877
-44.31%
Shares
Shares Volume: 359,606 Shares
Average Share Price: $2.85
INSIDER
BERGER FRANKLIN M
Director
reported on Dec 12 2024
traded on Dec 10 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 451,897 |
| PURCHASES/SALES 1Y | 0 / 1 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $1,024,877.1 |
| INSIDER PREVIOUS TRADES | No trades in past 1Y |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 0 / 10 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $181,179.42 |
| COMPANY PREVIOUS TRADES |